Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when PTCT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: PTCT PTC THERAPEUTICS, INC. 8-K

PTC Therapeutics director Alethia Young resigns to focus on other work, stays on as advisor

Filed June 9, 2026 · Period ending June 8, 2026 · ~1 min read

2 key changes 1 section

Key Changes

  • low

    Board member Alethia Young resigned effective June 8, 2026, citing need to focus on other work commitments. Company states departure was not due to any disagreement.

    Item 5.02 verify on EDGAR →
  • low

    Young will continue as paid advisor through June 2027 under consulting agreement paying $4,167 monthly (approximately $50,000 annually).

    Item 5.02 verify on EDGAR →

Summary

PTC Therapeutics disclosed a routine board change as director Alethia Young stepped down effective June 8, 2026. The company emphasized her departure was voluntary and driven by her need to focus on other professional commitments, not by any disagreement with management or company direction. To retain her expertise, PTC immediately entered a one-year consulting agreement with Young running through June 2027.

She'll receive roughly $50,000 annually to serve as an advisor. This arrangement is relatively common when valued directors leave due to time constraints rather than concerns about company performance. For retail investors, this is a non-material governance update with no operational or financial impact. Watch for any announcement of Young's replacement on the board, which would signal how PTC plans to fill her expertise gap in its director composition.

Section-by-Section Diff

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

PTC Therapeutics filed an 8-K to disclose a consulting services agreement with Alethia Young.

1 Added
Show 1 minor / wording change
Added Consulting Services Agreement low

Added in current filing · verify on EDGAR →

Consulting Services Agreement between the Registrant and Alethia Young

PTC Therapeutics entered into a consulting services agreement with Alethia Young. The 8-K does not provide details about the scope, duration, or compensation terms of the consulting arrangement.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify